One-year results from the FUTURE-II trial ...Middle East

A decade already passed from the first use of bioresorbable vascular scaffold in percutaneous coronary interventions. The first studies - by using surrogate endpoints - showed some superiority of BRS vs. metallic drug-eluting stent in terms of the so-called vascular restoration therapy with recovery of vasomotion and vascular pulsatility when the scaffold was absorbed....

Hence then, the article about one year results from the future ii trial was published today ( Tuesday 18/05/2021 - 10:30 AM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( One-year results from the FUTURE-II trial )

Also on site :

• 'Came here in good faith but ... ': JD Vance on why Iran peace talks failed
• Saudi Arabia suspends in-person classes in multiple regions amid heavy rain
• Khoros lance Aurora AI : une nouvelle ère pour la communauté des entreprises